ES2000128A6 - Procedimiento de preparacion de nuevos derivados peptidicos de estructura lactonica o cicloamidica - Google Patents

Procedimiento de preparacion de nuevos derivados peptidicos de estructura lactonica o cicloamidica

Info

Publication number
ES2000128A6
ES2000128A6 ES8600846A ES8600846A ES2000128A6 ES 2000128 A6 ES2000128 A6 ES 2000128A6 ES 8600846 A ES8600846 A ES 8600846A ES 8600846 A ES8600846 A ES 8600846A ES 2000128 A6 ES2000128 A6 ES 2000128A6
Authority
ES
Spain
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
cycloamidic
lactonic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8600846A
Other languages
English (en)
Inventor
Michel Vincent
Georges Remond
Jean Lepagnol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of ES2000128A6 publication Critical patent/ES2000128A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UN PROCEDIMIENTO DE PREPARACION DE LOS DERIVADOS DE FORMULA GENERAL: EN LA CUAL: A ES UN GRUPO LACTONICO O CICLOAMIDICO, B REPRESENTA CON LOS ATOMOS DE CARBONO Y DE NITROGENO A LOS CUALES ESTA UNIDO UNA ESTRUCTURA POLICICLICA SATURADA, R1 REPRESENTA UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO O UN GRUPO 4-IMIDAZOLIL METILO EVENTUALMENTE SUSTITUIDO, R2 Y R3, IDENTICOS O DIFERENTES, REPRESENTAN UN ATOMO DE HIDROGENO O UN RADICAL ALQUILO, O FORMAN JUNTOS UN HETEROCICLO, SUS ENANTIOMEROS O DIAESTEREOISOMEROS Y SUS SALES. MEDICAMENTOS.
ES8600846A 1985-08-05 1986-08-04 Procedimiento de preparacion de nuevos derivados peptidicos de estructura lactonica o cicloamidica Expired ES2000128A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8511936A FR2585709B1 (fr) 1985-08-05 1985-08-05 Nouveaux derives peptidiques a structure lactonique ou cycloamidique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ES2000128A6 true ES2000128A6 (es) 1987-12-16

Family

ID=9321967

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8600846A Expired ES2000128A6 (es) 1985-08-05 1986-08-04 Procedimiento de preparacion de nuevos derivados peptidicos de estructura lactonica o cicloamidica

Country Status (15)

Country Link
US (1) US4725581A (es)
EP (1) EP0217688B1 (es)
JP (2) JPS6233198A (es)
AT (1) ATE56976T1 (es)
AU (1) AU581599B2 (es)
CA (1) CA1276397C (es)
DE (1) DE3674525D1 (es)
DK (1) DK364786A (es)
ES (1) ES2000128A6 (es)
FR (1) FR2585709B1 (es)
GR (1) GR862059B (es)
IE (1) IE58541B1 (es)
NZ (1) NZ217079A (es)
PT (1) PT83145B (es)
ZA (1) ZA865826B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0696575B2 (ja) * 1987-09-17 1994-11-30 三菱化成株式会社 ４−アミノピリジン誘導体及びその酸付加塩
GB2227658A (en) * 1989-02-03 1990-08-08 Cellana Thyrotropin releasing hormone (trh) composition for enhancing immune function
FR2649110B1 (fr) * 1989-06-29 1994-10-21 Adir Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2663336B1 (fr) * 1990-06-18 1992-09-04 Adir Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5504071A (en) * 1990-10-03 1996-04-02 Polifarma S.P.A. Compounds with a sequence of three radicals, the central one being α-a
IT1242002B (it) * 1990-10-03 1994-02-02 Polifarma Spa Composti con attivita' farmacologica antiipertensiva, analgesica, immunomodulante e antiinfiammatoria, che presentano nella molecola una sequenza di tre radicali, essendo alfa-amminoacido quello centrale
FR2694295B1 (fr) * 1992-07-28 1994-09-02 Adir Nouveaux peptides dérivés de trifluoromethylcetones, leur procéde de préparation et les compositions pharmaceutiques qui les contiennent.
AU1757597A (en) * 1996-02-05 1997-08-22 Eli Lilly And Company Method of treating beta-amyloid peptide associated conditions using trh
DE19616509A1 (de) * 1996-04-25 1998-01-15 Asta Medica Ag Neue spezifische Immunophilin-Liganden als Antiasthmatika, Immunsuppressiva
AU2003248584A1 (en) * 2002-03-01 2003-09-16 Warner-Lambert Company Llc Method of treating osteoarthritis
US7628342B2 (en) 2004-05-11 2009-12-08 Daiwa Can Company Liquefied gas dispensing nozzle and liquefied gas dispensing apparatus
EP1993527A4 (en) 2006-01-26 2009-08-05 Univ Rochester INHIBITION OF AMYLOID BETA PEPTIDE / RAGE INTERACTION AT BLOOD BRAIN BARRIER

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944308B2 (ja) * 1976-03-23 1984-10-29 武田薬品工業株式会社 ペプタイド
US4260601A (en) * 1979-10-23 1981-04-07 Nyegaard & Co. A/S Chemical compounds
US4293481A (en) * 1980-07-24 1981-10-06 E. R. Squibb & Sons, Inc. Tripeptide inhibitors of angiotensin-converting enzyme
JPS57188526A (en) * 1981-05-14 1982-11-19 Takeda Chem Ind Ltd Peptide-containing pharmaceutical preparation
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
DE3332633A1 (de) * 1983-09-09 1985-04-04 Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel

Also Published As

Publication number Publication date
ATE56976T1 (de) 1990-10-15
PT83145A (fr) 1986-09-01
EP0217688A1 (fr) 1987-04-08
IE58541B1 (en) 1993-10-06
AU6081286A (en) 1987-02-12
NZ217079A (en) 1988-05-30
JPH0229680B2 (es) 1990-07-02
ZA865826B (en) 1987-04-29
GR862059B (en) 1986-12-24
JPS6233198A (ja) 1987-02-13
AU581599B2 (en) 1989-02-23
DE3674525D1 (de) 1990-10-31
JPH01230597A (ja) 1989-09-14
EP0217688B1 (fr) 1990-09-26
CA1276397C (fr) 1990-11-13
FR2585709B1 (fr) 1987-10-02
PT83145B (pt) 1989-03-30
US4725581A (en) 1988-02-16
IE862085L (en) 1987-02-05
DK364786D0 (da) 1986-07-31
FR2585709A1 (fr) 1987-02-06
JPH0259160B2 (es) 1990-12-11
DK364786A (da) 1987-02-06

Similar Documents

Publication Publication Date Title
GEP20084347B (en) New derivatives of diphosphonic acid, method for their preparation and medicamentous form containing them
NO173726C (no) Fremgangsmaate for fremstilling av et oralt terapeutisk system for administrering av karbamazpin
ES2000128A6 (es) Procedimiento de preparacion de nuevos derivados peptidicos de estructura lactonica o cicloamidica
GB8420771D0 (en) Treatment of skin disorders
IL73292A0 (en) Kit for administering gangliosides and derivatives thereof by inhalation and pharmaceutical composition suitable therefor
GB8828694D0 (en) Preparation for introducing active substance for regulating tanning into skin production & use thereof
EP0388799A3 (en) Use of human interferon-beta for stimulation of erythropoieses
Poschel et al. Arousal deficit shown in aged rat's quantitative EEG and ameliorative action of pramiracetam compared to piracetam
ES2009689A6 (es) Procedimiento para preparar derivados de 3-piperidina-carbaldehido-oxima.
GB8808598D0 (en) Pharmaceutical compositions for treatment of prophylaxis of skin disorders
IL78307A0 (en) Psoralene-based bath composition for treatment of skin disorders
FR2575158B1 (fr) Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
JPS5753475A (en) Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same
PT85593A (en) Process for preparing substituted hexahydroarylquinolizines
HUT39449A (en) Process for producing new benzazepine derivatives and pharmaceutical compositions containing them
Alexopoulos et al. Unilateral electroconvulsive therapy: an open clinical comparison of two electrode placements.
AU1306388A (en) Preparation for treatment of skin disorders
Elsendoorn Acceptability of temporal variations in synthetic speech: A preliminary investigation.
ES2007415A6 (es) Procewdimiento de obtencioon de citidina-difosfo-dimetiletanolamina.
HUT47579A (en) Process for production of new imidazo /1,2-a/-pirimidins and their salts and medical compositions containing them as active substance
Kuzminskaya et al. Cholinesterase activity and ATP in development of long-term neurotoxicity caused by tri-o-cresyl phosphate.
IE842027L (en) Treatment of skin disorders
HU895238D0 (en) Process for the preparation of pharmaceutical composition suitable for the treatment of pyogenous skin diseases
UA7216A1 (uk) Спосіб одержання похідних 12-аміно-пірідазіно[4', 5':3,4]-пірроло[2,1-а] ізохіноліна або їх фізіологічно переносимих кислотно-аддітивних солей
HU895239D0 (en) Process for the preparation of pharmaceutical compositions suitable for the treatment of skin diseases

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001009